Wednesday, February 06, 2008

cancer news

The National Bone Marrow Transplant Link (nbmt Link) presents a Telephone Education and Support Group for Bone Marrow/Stem Cell Transplant Survivors Coping with Chronic GVHD. Facilitated by Sandra Mitchell and Kate Castro of the National Institutes of Health, this free teleconference will take place in the spring and fall 2008 on Wednesdays from 7:00 - 8:15 PM EST. For more information or to register, please call Tiffany Rowe at 800-546-5268 or email: tiffanyrowe@nbmtlink.org


Registration is now open for a free Parents of Post Transplant Children: Telephone Support Group offered by the National Marrow Donor Program's Office of Patient Advocacy in cooperation with the National Bone Marrow Transplant Link. The group will address survivorship issues following bone marrow/stem cell transplant and is available for parents/guardians whose children are beyond 100 days post-transplant and have returned home from their transplant center. If you have questions or would like to register, call toll free 888-999-6743 or e-mail: patientinfo@nmdp.org


The Leukemia Research Foundation is convening a Transplant Conference on "Bone Marrow, Stem Cell, and Cord Blood Transplants: Is One of These Therapies Right for You? Who Can Benefit and When?" on Saturday, March 15, 2008 at the Westin O'Hare, Rosemont, IL. This all day conference is specifically designed for patients and caregivers to provide information on available treatments for leukemia, lymphoma, and other blood-related disorders. There is a $15.00 registration fee. Breakfast and lunch are included and parking is free. For additional information or reservations call 847-424-0600 or click here.


The National Institute of Nursing Research (NINR) at the National Institutes of Health (NIH) is currently recruiting patients for a clinical trial testing the effects of topical thalidomide gel in patients who have developed chronic GVHD related oral mucositis following allogeneic stem cell transplantation. Patients between 18 and 80 years of age who have received a SCT and developed oral chronic GVHD may be eligible for this study. If you are interested in participating or would like to additional information, please contact Tara Cozzarelli at 301-451-1683 or email: cozzaret@mail.nih.gov

0 Comments:

Post a Comment

<< Home